HQ
abrdn Life Sciences Investors (HQL)
NYSE·Financial Services·Asset Management
$17.89
+1.07%
Mkt Cap $486.36M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$227.70
Range $154.44 – $267.30
Implied Upside
+1172.8%
Consensus $227.70 vs current $17.89